Literature DB >> 7034521

Simultaneous enzyme immunoassay of carcinoembryonic antigen in pleural effusion and serum.

P P Asseo, G D Tracopoulos.   

Abstract

A carcinoembryonic antigen (CEA) enzyme immunoassay test was used to estimate its value in the differential diagnosis of malignant and non-malignant pleural effusions. Paired pleural fluid and serum CEA determinations were performed in 107 patients, 53 with malignant and 54 with non-malignant pleural disease. CEA values uniformly lower than a cut-off level of 5.0 ng/ml were found in the pleural fluid and the serum in the non-malignant group, whereas in the malignant group, values higher than the cut-off level were present in the pleural fluid in 37 (69.8%), and in the serum in 30 (56.6%) of the examined patients. All 30 patients with elevated serum CEA levels also had pleural fluid CEA above 5.0 ng/ml. The results of this study demonstrate that although pleural fluid CEA values below 5.0 ng/ml do not exclude malignancy, increased values strongly suggest that the fluid is of malignant origin. Pleural fluid CEA determination had a 13.2% higher sensitivity, compared with that of the serum, in detecting malignant pleural involvement, yet with no statistical significance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7034521     DOI: 10.1093/ajcp/77.1.66

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Tumour associated antigens in diagnosis of serous effusions.

Authors:  J Mezger; W Permanetter; A L Gerbes; W Wilmanns; R Lamerz
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

2.  Carcinoembryonic antigen-positive pleural effusion in early stage non-small cell lung cancer without pleural infiltration.

Authors:  Njanja Enz; Fernando Fragoso; Alexander Gamrekeli; Frank Lippek; Wolfgang Jungraithmayr
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

3.  Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.

Authors:  M Miédougé; P Rouzaud; G Salama; M C Pujazon; C Vincent; M A Mauduyt; J Reyre; P Carles; G Serre
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.